Northern Trust Company of Connecticut’s Gilead Sciences GILD Stock Holding History

Northern Trust Company of Connecticut’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$75.8M	Sell	1,009,914 -188,928	-16%	-$13.2M	0.48%	21
2013 Q3	$75.4M	Sell	1,198,842 -53,435	-4%	-$3.19M	0.49%	19
2013 Q2	$64.2M	Buy	+1,252,277	New	+$65.3M	0.44%	24

Other funds holding GILD

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Company of Connecticut's GILD Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Gilead Sciences (GILD) stake by 16% in Q4 2013, selling an estimated $13.2M and leaving 1,009,914 shares worth $75.8M. The position accounts for 0.48% of the portfolio, ranked #21.

Northern Trust Company of Connecticut first reported a position in GILD in Q2 2013 and has held it in 3 quarters since. 1,100 funds tracked by Wall St. Rank hold GILD as of Q4 2013.

Northern Trust Company of Connecticut held 1,009,914 shares of Gilead Sciences worth $75.8M as of Q4 2013.
Northern Trust Company of Connecticut sold 188,928 Gilead Sciences shares in Q4 2013, an estimated $13.2M.
Gilead Sciences made up 0.48% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #21 holding.
Northern Trust Company of Connecticut first reported a position in Gilead Sciences in Q2 2013 and has held it in 3 quarters since.
1,100 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.